[Use of myelopid in the complex treatment of patients with destructive pulmonary tuberculosis].
A complex immunotherapy regimen containing myelopid in combination with chemotherapeutic drugs was prescribed for 30 patients aged from 17 to 54 years and suffering from destructive pulmonary tuberculosis. It was proved that a complex treatment favored the normalization of the main immunologic indices, thus greatly increasing the efficacy of pulmonary tuberculosis patient management.
Vakhidova
G A
GA
Vasil'eva
F R
FR
Kurbanova
R R
RR
Stepanenko
R N
RN
Ubaĭdullaev
A M
AM
D000276:Adjuvants, Immunologic / Q000008:administration & dosage; D000293:Adolescent; D000328:Adult; D000818:Animals; D000995:Antitubercular Agents / Q000008:administration & dosage*; D001402:B-Lymphocytes / Q000187:drug effects / Q000276:immunology; D006801:Humans; D008213:Lymphocyte Activation / Q000187:drug effects; D008875:Middle Aged; D009842:Oligopeptides; D010455:Peptides / Q000008:administration & dosage*; D010587:Phagocytosis / Q000187:drug effects; D012397:Rosette Formation; D013601:T-Lymphocytes / Q000187:drug effects / Q000276:immunology; D014397:Tuberculosis, Pulmonary / Q000188:drug therapy* / Q000276:immunology
D000276:Adjuvants, Immunologic; D000995:Antitubercular Agents; D009842:Oligopeptides; D010455:Peptides; C048617:myelopeptides
Primenenie mielopida v kompleksnom lechenii bol'nykh destruktivnym tuberkulezom legkikh.